pallerlab.bsky.social
👤 Joined on 18 November 2024
Followers
Following
Total Posts
@pallerlab.bsky.socialTralokinumab treatment for up to 1 year has no clinically relevant effect on laboratory parameters in adolescents with moderate to severe #AtopicDermatitis. #DermSky @pallerlab.bsky.social
Show PostImportant conversation between leading experts, Drs. Amy Paller and Peter Lio, on the evolving link between atopic dermatitis and food allergy risk. 🎥 Watch the discussion unfold, full interactive video here: hubs.la/Q03hG1rh0 #AtopicDermatitis #FoodAllergy #Dermatology #Pediatrics
Show PostAt #RAD2025, Dr. Amy Paller highlighted new data on disease/ family burden of #AtopicDermatitis in children aged <6 years. View her discussion here: www.hcplive.com/view...
Show PostCome and join the peer review discussion (1-2pm today) at #SIDSanDiego25 (Sapphire A/B) with Amy Paller, Amanda Nelson, Ayman Grada, Russell Hall @thejidinnovations.bsky.social, Erwin Tschachler @thejidjournal.bsky.social and Elizabeth Blalock @thejidjournal.bsky.social
Show PostCan atopic dermatitis be a risk factor for the development of food allergies? Join experts Amy Paller and Peter Lio in our full interactive video to learn more: hubs.la/Q03hG1Py0 This program is nonpromotional and is sponsored by Sanofi and Regeneron Pharmaceuticals.
Show Post